摘要 |
<p>The present invention relates to the field of cancer chemotherapy. More particularly, the present invention relates to a compound for improving the effectiveness of cancer chemotherapy by preventing, reducing, or reversing the development of cellular resistance to chemotherapeutic agents, i.e., the phenomenon known as 'multidrug resistance' (MDR), during the course of therapy. This is achieved by administering to patients N-alkyl-1,5-dideoxy-1,5-imino-D-glucitol or galactitol compounds ('iminosugars') in conjunction with chemotherapeutic drugs.</p> |